Fremont, CA, United States of America

Roger Farhnoltz



Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Roger Farhnoltz in Lung Treatment

Introduction

Roger Farhnoltz is an accomplished inventor based in Fremont, California. He has made significant contributions to the field of pulmonary medicine, particularly through his innovative patents. With a total of four patents to his name, Farhnoltz has focused on developing advanced medical devices aimed at improving lung health.

Latest Patents

One of Farhnoltz's latest patents involves functional assessment and treatment catheters designed for use in the lung. This invention allows for the diagnosis and optional treatment of lung conditions using a functional assessment catheter. A flow restrictive component is placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter while the flow restrictive component remains in place. If the patient is deemed a suitable candidate for treatment using occlusive or restrictive techniques, the flow resistive component may be left in place. Conversely, if the patient is not suitable for such treatment, the flow resistive component can be removed.

Career Highlights

Farhnoltz is currently employed at Pulmonx Corporation, where he continues to innovate in the field of lung health. His work has been instrumental in developing technologies that enhance the diagnosis and treatment of lung diseases.

Collaborations

Throughout his career, Farhnoltz has collaborated with notable colleagues, including Ajit Nair and Son M Gia. These partnerships have contributed to the advancement of his inventions and the overall mission of improving patient outcomes in pulmonary care.

Conclusion

Roger Farhnoltz's contributions to lung treatment through his innovative patents highlight his dedication to advancing medical technology. His work at Pulmonx Corporation and collaborations with esteemed colleagues further emphasize his impact in the field of pulmonary medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…